Page 1661 - Clinical Small Animal Internal Medicine

Index 1599

DI see diabetes insipidus; distraction diaphragm 295 pleural effusion 342
VetBooks.ir diabetes insipidus (DI) 65–66, 66, 68 chronic enteropathies 627–629, portosystemic shunts and
diarrhea
index
polyuria and polydipsia 66
diabetes mellitus (DM) 93–102
microvascular dysplasia 717
634–637
autoimmune polyglandular exocrine pancreatic rectoanal diseases 610, 612, 614,
syndromes 113–115 insufficiency 584–585 616, 619
cataracts 95–96, 95 feline inflammatory liver septic shock 428
classification 93 disease 688 superficial necrolytic
diabetic ketoacidosis 100 feline parvovirus 870 dermatitis 1492–1493
diabetic neuropathy 96, 96 motility disorders 570–572, urolithiasis 1137–1144
diagnosis 96–97 574–577 vestibular disease 793–794
endocrinology 32 nocosomial and multidrug‐resistant diffuse iris melanomas 1265, 1265
epidemiology 94 infections 1058 diffuse parenchymal disease 665–666
etiology/pathophysiology 93, 94 rectoanal diseases 615 diffusion impairment 386
feline acromegaly 43–48 DIC see disseminated intravascular 1,25‐dihydroxyvitamin D
hepatic lipidosis 678 coagulation 1521–1522, 1525–1527
hepatomegaly 95 diet and nutrition dilated cardiomyopathy (DCM)
history and clinical signs 94–96, acute kidney injury 1097–1098 canine myocardial disease
95, 96 atopic dermatitis 1409–1410 253–262
insulin resistance 93, 99–100 canine inflammatory liver disease cardiogenic shock 413–415
pancreatitis 608 701, 703 cardiovascular disease 119,
polyphagia 94 chronic enteropathies 627–629, 122–124, 137
polyuria and polydipsia 65 634–637 diagnosis 255–259, 255–257, 258
polyuria and polydypsia 94, 96 chronic kidney disease 1166 electrocardiography 174
prognosis 100–101 cirrhosis 710 epidemiology 254
signalment 94 critical care setting 351 etiology/pathophysiology 253–254
sodium and water homeostasis 1071 cutaneous adverse food feline myocardial disease 267,
superficial necrolytic reactions 1419–1422 269–271
dermatitis 1491–1493 cutaneous manifestations of systemic heart failure 178, 189–190, 192,
systemic hypertension 220 disease 1486–1487 194, 196
treatment 94, 97–100, 98–100 developmental orthopedic history and clinical signs 254–255
weight change 94 diseases 1540–1541, 1548 lymphomas 1234
diabetic ketoacidosis (DKA) 100, 592 diabetes mellitus 97–101 prognosis 262
diabetic neuropathy 96, 96 dysbiosis 623 signalment 254
diacylglycerol (DAG) 179 end‐of‐life care 1559 treatment 259–262, 260
dialysis 1175–1180 enteral nutrition 452–453, ventricular arrhythmias 200, 201
acute intoxications and therapeutic 679, 1097 dilated pupil syndrome 828
plasma exchange 1179–1180 exocrine pancreatic direct fluorescent antibody (DFA)
acute kidney injury 1098, insufficiency 583, 589 test 894, 953
1176–1178, 1176–1177 feline hyperthyroidism 76, 78–79 direct oral anticoagulants
availability and prognosis 1180 feline inflammatory liver (DOAC) 321
azotemia/uremia 1176–1177 disease 691–693 discoid lupus erythematosus
chronic kidney disease 1172, forebrain disorders 780 (DLE) 1424–1425, 1426
1178–1179 gastritis and gastric ulceration 554 disease‐modifying osteoarthritis agents
continuous renal replacement glomerular disease 1105 (DMOA) 1534–1536
therapy 1098, 1150, 1175–1176 heart failure 188, 192 disease surveillance 4
fluid overload/oliguria/ metabolic diseases 679, 682–683 disinfection see cleaning and
anuria 1177–1178 motility disorders 577 disinfection
hyperkalemia 1177–1178 osteoarthritis 1532–1533 displacement of the colon 505
intermittent hemodialysis pancreatic endocrine disseminated intravascular coagulation
1149–1150, 1175–1176 tumors 1299–1300 (DIC)
modalities 1175–1176 pancreatitis 597–599, 606–608 cirrhosis 706
peritoneal dialysis 1175–1176 phosphorus homeostasis and Ebola virus 901
severe acidemia 1178 disorders 1079–1080, 1085 hyperthermia 434